Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
about
Autoimmune liver serology: current diagnostic and clinical challengesThe changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c miceAutoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyAdaptive immunity in the liverUpdate on Autoimmune HepatitisAutoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future ResearchRegulatory T cells: Mechanisms of suppression and impairment in autoimmune liver diseaseReview article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targetsDietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-γ ExpressionImmunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsAutoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristicsSex bias in experimental immune-mediated, drug-induced liver injury in BALB/c mice: suggested roles for Tregs, estrogen, and IL-6Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failureApoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity.Treatment of autoimmune liver disease: current and future therapeutic options.Liver immunology.Review article: autoimmune hepatitis -- current management and challenges.High levels of soluble CTLA-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitisMedullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model.Autoimmune hepatitis: a review of current diagnosis and treatment.Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells.Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis.Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies.Immunopathogenesis of primary biliary cirrhosis: an old wives' tale.Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids.Regulatory T Cells in Autoimmune and Viral Chronic HepatitisTolerance Induction in LiverThe Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of DiseaseEpstein-barr virus as a trigger of autoimmune liver diseases.Sex differences associated with primary biliary cirrhosis.Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?New Approaches for Studying Alcoholic Liver DiseaseRheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence?
P2860
Q24644140-827ACD1C-8A5A-4D0A-9E78-E43F7458D5F7Q24805327-AAF683D5-7E79-4D5C-A7AB-6B52CB5600C6Q26742101-506A7D54-1C40-4A72-8376-F11FFBBEEB95Q26753195-C716D63A-E7FF-4BA0-ACB8-3C07D1A58D29Q26781765-0CBE4374-5CF4-4292-8137-472B368BF1E6Q26786188-C26389C4-DCD3-4FA1-9E82-0A4387DC4999Q26827787-10EFF93F-B9AB-4934-97CD-DE84496BF7CCQ27025680-B61023FF-625E-4A59-994A-D2F63AAC60C5Q27302829-DD2D7F4C-5F65-4C41-8192-44A369DA827CQ28069584-E5AB6799-D05A-4C2D-8409-DA110A81FE1AQ28076505-FDEA9C53-6B5E-44D6-AE27-FA7A9845DE4CQ28087726-D4E0BEC9-4F0B-4011-8DD7-A1C7909B3DACQ28486040-A2BD2DED-8B5A-4FFE-8331-C50033D7D629Q28542378-79EA4D76-8117-4FC1-99D6-26754D817A88Q30439284-84A54ACD-2547-47A1-AA87-62ADD297CF5CQ33883569-83A30B58-D1EC-4EC5-889B-6A04556D71AEQ34071745-8C018237-826A-4E1F-ADE7-6F948E83F484Q34342199-9627721D-FB01-4FAD-8624-0D5665F8E264Q34359990-A3217D02-65D6-48A2-9E19-DCF9025E1E07Q34369116-D0036E29-DAE0-475D-9FDB-5953A0FC870EQ34482952-5DF022D5-6CAB-4988-AE72-B5776613FBDBQ34570969-604EAE1D-9A73-4B3F-A6C9-F63451FDAE93Q35016702-C977F2E2-5A73-47A3-BBD9-0C502D323D8AQ35094267-8CC29B6D-C522-4B24-87C2-C9F850FF0D1DQ35157701-FE179F0C-E26D-4689-98EE-365BD0F0C098Q35309080-8DE65C28-E1A5-4074-9529-DEB186CD3CC8Q35309836-B3573A6D-11BC-47F6-8011-231D3872F889Q35309854-D69F2C6E-2ADA-449C-A59A-60F4133462F3Q35614763-0178A4B7-7D5A-4F58-B7B5-67457110AE6BQ35638169-7AF2DE4A-AC05-4EEB-A8FA-556A1097DDEAQ35725777-5F8D1B64-7441-4693-9523-73DC5CBB5EFAQ35727669-E6D6F15A-27B0-40E2-BC66-8016AF7D9B78Q35849575-25F5E6F7-0F1C-499E-9E66-5A879C2DE973Q35870141-327D6443-3317-4AE8-A86F-7B2DEE167660Q35906055-0448D929-431B-4386-9211-7A1CF41A4572Q36010920-52A3916C-030C-4752-BBA3-5669122F8B95Q36014535-DDA8F278-2B40-451D-BB32-9DE3D611A948Q36248162-BFF342F1-F382-445F-AE15-75D233C0BBC5Q36288405-9015AB5D-0B76-4C15-A9FB-DBA4B42DE60CQ36369284-805EAEF7-791D-4554-9A10-332AA382FEF5
P2860
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Impairment of CD4
@nl
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
@en
type
label
Impairment of CD4
@nl
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
@en
prefLabel
Impairment of CD4
@nl
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
@en
P2093
P1476
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease
@en
P2093
Diego Vergani
Giorgina Mieli-Vergani
Maria Serena Longhi
Paul Cheeseman
P356
10.1016/J.JHEP.2004.03.008
P577
2004-07-01T00:00:00Z